- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/227 - Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
Patent holdings for IPC class C07D 215/227
Total number of patents in this class: 377
10-year publication summary
54
|
31
|
40
|
23
|
30
|
23
|
18
|
18
|
24
|
15
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alkermes Pharma Ireland Limited | 270 |
17 |
Janssen Pharmaceutica N.V. | 3396 |
16 |
Gilead Sciences, Inc. | 2031 |
12 |
Corteva Agriscience LLC | 2662 |
10 |
Syngenta Participations AG | 1907 |
6 |
Glaxosmithkline Intellectual Property (no.2) Limited | 288 |
6 |
Abbvie Inc. | 1800 |
6 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 286 |
6 |
The Regents of the University of California | 19857 |
5 |
Bayer Pharma AG | 1061 |
5 |
Amgen Inc. | 4071 |
5 |
Biogen MA Inc. | 893 |
5 |
General Mills, Inc. | 1020 |
5 |
Symberix, Inc. | 7 |
5 |
Syngenta Limited | 457 |
4 |
AbbVie Deutschland GmbH & Co. KG | 263 |
4 |
Crystal Pharma, S.A.U. | 50 |
4 |
Forma Therapeutics, Inc. | 159 |
4 |
Otsuka Pharmaceutical Co., Ltd. | 1499 |
4 |
Rutgers, The State University of New Jersey | 1890 |
4 |
Other owners | 244 |